search
Documents
Chiral Analysis of Atomoxetine | Phenomenex
In this technical note, we report the chiral separation of racemic Naproxen using the immobilized polysaccharide-based chiral stationary phase Lux i-Amylose-1. Under optimal conditions, the racemic Naproxen was efficiently separated with a resolution factor of 2.33 and a separation factor (alpha) of 1.16. This method can be used for the enantiomeric separation and purity assessment of S-Naproxen, the Active Pharmaceutical Ingredient (API).
Chiral Analysis of Atomoxetine | Phenomenex
In this technical note, we report the chiral separation of racemic Naproxen using the immobilized polysaccharide-based chiral stationary phase Lux i-Amylose-1. Under optimal conditions, the racemic Naproxen was efficiently separated with a resolution factor of 2.33 and a separation factor (alpha) of 1.16. This method can be used for the enantiomeric separation and purity assessment of S-Naproxen, the Active Pharmaceutical Ingredient (API).
Document Type:
Technical Notes
Target Industries:
Techniques:
Brands:
Separation Modes:
Normal Phase, Chiral
Phases:
Chiral Analysis of Atomoxetine | Phenomenex
In this technical note, we report the chiral separation of racemic Naproxen using the immobilized polysaccharide-based chiral stationary phase Lux i-Amylose-1. Under optimal conditions, the racemic Naproxen was efficiently separated with a resolution factor of 2.33 and a separation factor (alpha) of 1.16. This method can be used for the enantiomeric separation and purity assessment of S-Naproxen, the Active Pharmaceutical Ingredient (API).
| Target Industries: | Pharmaceutical |
| Techniques: | HPLC |
| Brands: | Lux, SecurityGuard |
| Separation Modes: | Normal Phase, Chiral |
| Phases: | Lux i-Amylose-1 |
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.